MedexTestGlobal Pte. Ltd.

A new era in disease detection

STREET ADDRESS: 22a theobalds Road, London WC1X 8PF, United kingdom
EMAIL: info@medextestglobal.com
TELEPHONE: 020-7405-2626
FACSIMILE: 020-7405-2727
POSITION: International Executive and Marketing
KEY CONTACT: Keith Bushnell
EMAIL: keithb@medextestglobal.com

PR & COMMUNICATION: Health Squared Communications Limited.
POSITION: PR & Communication
KEY CONTACT: Abigail

POSITION: CFO/Investments
KEY CONTACT:  Gavin Kaye
EMAIL: gavin@opus-health.com

POSITION: Product Demonstrator
KEY CONTACT: Johel Neiron
EMAIL: johel@medextestglobal.com


COMPANY OVERVIEW:

MedexTestGlobal Pte. Ltd. has exclusive worldwide rights to the distribution of the flagship product, Medex Test, a revolutionary early-diagnostic health screening system. With the fusion of medical science and a hi-tech interpretive computer program, it is now the leading company in the world with this early diagnostic ability.



INTERNATIONAL PROGRESS:

The company has established offices in Australia, Singapore, and Germany to facilitate international marketing, distribution, administration, and support for on-going clinical trials.

Clinical trials have been performed and are on-going in Australia, Malaysia, Singapore, Netherlands, Italy, Germany and various other European locations.

Selected hospitals and clinics in Singapore, Taiwan, Philippines, Thailand,  and Korea have recently begun preliminary testing on the potentially expanded disease detection capabilities of the Medex Test .

The Medex Test system was recently released into the United Arab Emirates.



APPOINTMENT OF DR. PITONO TO THE MEDICAL BOARD OF DIRECTORS:

Dr. Pitono Yap Siauw Pik

Parkway Group of Hospitals, Eastshore Hospital, Singapore

Formal Education:
1979 -1985 School of Medicine, University of Brawijaya, Malang, Indonesia - Medical Doctor.

Functions as member of the MedexTestGlobal medical team. Acts as Marketing Manager for well known Parkway Group of Hospitals in Singapore.

Recently commissioned by Medex to participate in an international course of study and conduct clinical trials in hospitals with his counterpart Australian Dr. De Souza.